← All stocks

BioCardia, Inc.

BCDA Net buying

CIK 0000925741 #5154 in the set updated 17 Sep 2026

Bought (120 mo)

$9.61M

out of their own pocket, the only kind of buying there is

Sold (120 mo)

$2.59M

$0.00 on a plan · $0.00 straight out of an exercise

Sold at will

$2.59M

5 of 5 sales

Net

+$7.03M

+$7.03M against sales at will

By person

18 insiders · 194 transactions

Insider

Role

Bought

Sold

Net

Holding

Worth

Change

STERTZER SIMON H

Director

$5.04M (27)

—

+$5.04M

848,936

$925.34K

—

Blank Andrew Scott

Director

$1.06M (4)

—

+$1.06M

988,277

$1.08M

—

Altman Peter

President and CEO

$611.44K (138)

$7.38K (1)

+$604.06K

381,985

$416.36K

—

Allen Jim L.

Director

$299.99K (1)

—

+$299.99K

109,753

$119.63K

—

FROST PHILLIP MD ET AL

10% owner

$2.50M (2)

$2.56M (2)

−$55.81K

14,771,343

$16.10M

−53.2%

McClung David

Chief Financial Officer

$53.92K (8)

—

+$53.92K

114,245

$124.53K

—

Facteau Bill

Director

$25.00K (1)

—

+$25.00K

13,123

$14.30K

—

KRASNO RICHARD M

Director

$25.00K (1)

—

+$25.00K

16,268

$17.73K

—

Duckers Eric

Chief Medical Officer

—

$16.95K (1)

−$16.95K

12,088

$13.18K

—

GILLIS EDWARD M

Senior Vice President, Devices

—

$6.51K (1)

−$6.51K

54,126

$59.00K

—

Allen Richard T

Vice President of Quality

—

823,125

$897.21K

—

MOYES JAY M

Director

—

54,267

$59.15K

+14,687%

PFENNIGER RICHARD C JR

Director

—

51,970

$56.65K

—

FERNANDEZ FERNANDO L

Director

—

40,644

$44.30K

—

TESSLER ALLAN R

Director

—

32,034

$34.92K

—

Quertermous Thomas

Director

—

15,681

$17.09K

+29.7%

Pesta Phil

Vice President of Operations

—

11,867

$12.94K

—

ZSEBO KRISZTINA M

Director

—

2,980

$3.25K

—

No percentages here. This company's share count has moved by a factor of 3.3 over the window, from 4,584,285 to 15,138,782 shares. A split, a merger or a large issue changes what the company is, and a holding measured at one point in that run is not a fraction of it at another.

Individual transactions

Nothing of that kind in this period.

What was left out

Form 4 filings counted 316

Amendments (4/A) skipped 11

Filings about a different issuer 0

Unreadable filings 0

Joint filings 4

Sales on a Rule 10b5-1 plan 0

Sales straight out of an exercise 0

Sales at will 5

Transactions with no price 0

Shares from compensation/vesting 3,783,173

Sales filed before the plan box existed 3

History held since 23 Dec 2016